SUBSCRIBE
SUBSCRIBE

Pfizer

NEWS
Pharm Country
Pfizer Inc. -- American’s Happiest Company?
December 10, 2012
 · 
1 min read
Pharm Country
Pfizer Inc. Multivitamin Reduces Cancer 8% in Men
October 17, 2012
 · 
1 min read
Biotech Bay
Accidental Blockbusters - Pfizer Inc.'s Viagra Made It Big Through Serendipity, Will Other Drugs?
October 5, 2012
 · 
1 min read
Biotech Bay
Analysis: Failed Alzheimer’s Drug May Get Second Chance, Pfizer Inc. Reveals
August 9, 2012
 · 
1 min read
Biotech Bay
Pfizer Inc.'s Avoidable Alzheimer’s Drug Failure
July 30, 2012
 · 
1 min read
Biotech Bay
What’s Next for the “Break Up Pfizer Inc."Theory?
June 8, 2012
 · 
1 min read
Biotech Bay
Abbott Laboratories’s Humira Could Have Been a Pfizer Inc. Drug
May 9, 2012
 · 
1 min read
Biotech Bay
Pfizer Inc., Eli Lilly and Company Help U.S. Test Failed Drugs for New Illness, National Institutes of Health (NIH) Reveals
May 4, 2012
 · 
1 min read
Biotech Bay
Pfizer Inc.'s Baby Formula Sale is One of Six Events That Will Set the Mood for Pharma Stocks
April 18, 2012
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
February 26, 2026
 · 
13 min read
Press Releases
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
February 26, 2026
 · 
4 min read
Press Releases
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
February 26, 2026
 · 
6 min read
Press Releases
U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
February 25, 2026
 · 
20 min read
Press Releases
Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China
February 24, 2026
 · 
3 min read
Press Releases
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
February 17, 2026
 · 
19 min read
Press Releases
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
February 17, 2026
 · 
18 min read
Press Releases
Pfizer Becomes Newest Partner Added to BaseLaunch’s Biotech Venture Incubator
February 10, 2026
 · 
2 min read
Press Releases
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
February 8, 2026
 · 
16 min read
Press Releases
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
February 6, 2026
 · 
5 min read
Load More